Patients with psychiatric diseases are 20 percent less likely to receive intravenous thrombolysis (IVT), an evidence-based therapy for improving outcomes after ischemic stroke, researchers from Johns Hopkins University reported in Stroke.

Though federal initiatives to expand health coverage under the Affordable Care Act (ACA) have been successful, more than one in 10 stroke survivors are still unable to afford their medication, experts reported at last week’s International Stroke Conference in Los Angeles.

Researchers are beginning to put their finger on what may be causing heart attack and stroke in people with few or no conventional risk factors. But they’re still figuring out what to do about it, The New York Times reports.

A new study is enrolling patients to evaluate whether bariatric surgery—normally reserved for the severely obese—is beneficial in a lighter subset of patients.

A pair of researchers at Utah State University are aiming to revolutionize the world of digital monitoring with a new technology that can measure a person’s heartbeat using nothing more than a video camera and specialized software, the university announced Monday.

DUBLIN and LEIPZIG — January 30, 2018 — Medtronic plc (NYSE: MDT) today added to its robust body of clinical evidence supporting the IN.PACT(TM) Admiral(TM) drug-coated balloon (DCB) with new presentations that demonstrated durable and consistent clinical outcomes in peripheral artery disease (PAD).

The prevalence of diabetes and hypertension in India is rising, with high numbers across the country and climbing rates among younger demographics, researchers reported in JAMA Internal Medicine this week.

Only a third of patients with retinal infarction underwent basic evaluations for stroke risk and fewer than one in 10 were seen by a neurologist, according to research presented at the International Stroke Conference on Jan. 25 in Los Angeles.